• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用半定量聚合酶链反应评估大鼠模型中卡氏肺孢子虫感染的发病及治疗情况。

Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model.

作者信息

O'Leary T J, Tsai M M, Wright C F, Cushion M T

机构信息

Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000, USA.

出版信息

J Clin Microbiol. 1995 Mar;33(3):718-24. doi: 10.1128/jcm.33.3.718-724.1995.

DOI:10.1128/jcm.33.3.718-724.1995
PMID:7751383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC228020/
Abstract

The use of semiquantitative PCR (SQPCR) to assess Pneumocystis carinii pneumonia (PCP) infection and its response to treatment was studied with rats. Groups of eight rats were immunosuppressed with steroids for 3 to 12 weeks. Untreated controls were maintained for the same periods. Three groups of rats were treated with pentamidine, three groups were treated with trimethoprim-sulfamethoxazole, and three groups of rats were tapered from steroids. At various times during suppression, rats from the different groups were sacrificed. At necropsy, lungs were lavaged to obtain bronchoalveolar fluids and then homogenized. Bronchoalveolar fluids and homogenates were assayed by cyst counting and SQPCR. An increase in the SQPCR signal was seen throughout immunosuppression, with a slow decrease upon the withdrawal of steroids and a faster decrease with drug treatment. SQPCR results with lung homogenates and bronchoalveolar fluids strongly correlated with each other and with cyst counts. These results warrant investigation of SQPCR for assessing treatment results of human P. carinii pneumonia infection.

摘要

利用大鼠研究了采用半定量聚合酶链反应(SQPCR)评估卡氏肺孢子虫肺炎(PCP)感染及其对治疗反应的情况。将八只大鼠分为一组,用类固醇进行免疫抑制3至12周。未治疗的对照组维持相同时间。三组大鼠用喷他脒治疗,三组用甲氧苄啶-磺胺甲恶唑治疗,三组大鼠逐渐减少类固醇用量。在免疫抑制期间的不同时间,处死不同组的大鼠。尸检时,对肺进行灌洗以获取支气管肺泡灌洗液,然后进行匀浆。通过囊泡计数和SQPCR对支气管肺泡灌洗液和匀浆进行检测。在整个免疫抑制过程中,SQPCR信号增加,停用类固醇后缓慢下降,药物治疗后下降更快。肺匀浆和支气管肺泡灌洗液的SQPCR结果彼此之间以及与囊泡计数密切相关。这些结果值得对SQPCR用于评估人类卡氏肺孢子虫肺炎感染的治疗结果进行研究。

相似文献

1
Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model.使用半定量聚合酶链反应评估大鼠模型中卡氏肺孢子虫感染的发病及治疗情况。
J Clin Microbiol. 1995 Mar;33(3):718-24. doi: 10.1128/jcm.33.3.718-724.1995.
2
The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection.使用巢式聚合酶链反应检测大鼠和人类感染中肺及血液中的卡氏肺孢子虫。
J Med Microbiol. 1995 Mar;42(3):209-13. doi: 10.1099/00222615-42-3-209.
3
Detection of Pneumocystis carinii in rats by polymerase chain reaction: comparison of lung tissue and bronchoalveolar lavage specimens.用聚合酶链反应检测大鼠卡氏肺孢子虫:肺组织与支气管肺泡灌洗标本的比较
Lab Anim Sci. 1996 Dec;46(6):628-34.
4
Identification of extrapulmonary Pneumocystis carinii in immunocompromised rats by PCR.通过聚合酶链反应在免疫受损大鼠中鉴定肺外卡氏肺孢子虫。
J Clin Microbiol. 1996 Jul;34(7):1660-5. doi: 10.1128/JCM.34.7.1660-1665.1996.
5
Establishment of rat model for Pneumocystis carinii infection and cloning of the surface glycoprotein A gene of Pneumocystis carinii.卡氏肺孢子虫感染大鼠模型的建立及卡氏肺孢子虫表面糖蛋白A基因的克隆
Di Yi Jun Yi Da Xue Xue Bao. 2002 May;22(5):427-9.
6
Amplification of Pneumocystis carinii DNA on specimens scraped from slides.从玻片刮取的标本上卡氏肺孢子虫DNA的扩增。
Diagn Microbiol Infect Dis. 1994 Mar;18(3):197-9. doi: 10.1016/0732-8893(94)90091-4.
7
Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.复方磺胺甲噁唑治疗不能逆转 HIV 感染合并肺孢子菌定植的非人类灵长类动物的阻塞性肺改变。
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):381-9. doi: 10.1097/QAI.0000000000000007.
8
Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Clin Infect Dis. 1993 Apr;16(4):519-22. doi: 10.1093/clind/16.4.519.
9
Pneumocystis carinii infection in young non-immunosuppressed rabbits. Kinetics of infection and of the primary specific immune response.幼龄非免疫抑制兔的卡氏肺孢子虫感染。感染动力学及初次特异性免疫反应
Med Microbiol Immunol. 1999 Aug;188(1):1-7. doi: 10.1007/s004300050098.
10
DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states.实验性肺孢子菌病中的DNA扩增:血清卡氏肺孢子菌DNA的特征及潜在的卡氏肺孢子菌携带状态
J Infect Dis. 1993 Aug;168(2):421-6. doi: 10.1093/infdis/168.2.421.

引用本文的文献

1
Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.肺炎:建立可靠动物模型的陷阱与障碍
J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129.
2
Toward a humanized mouse model of Pneumocystis pneumonia.迈向人类化肺炎支原体肺炎小鼠模型。
JCI Insight. 2021 Jan 25;6(2):139573. doi: 10.1172/jci.insight.139573.
3
Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs.通过聚合酶链反应(PCR)和口腔拭子证明新生大鼠早期感染卡氏肺孢子虫。
Eukaryot Cell. 2002 Jun;1(3):414-9. doi: 10.1128/EC.1.3.414-419.2002.
4
Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii.一种用于定量卡氏肺孢子虫卡氏变种的快速实时聚合酶链反应检测方法的开发。
J Clin Microbiol. 2002 Aug;40(8):2989-93. doi: 10.1128/JCM.40.8.2989-2993.2002.
5
Genetics of surface antigen expression in Pneumocystis carinii.卡氏肺孢子虫表面抗原表达的遗传学
Infect Immun. 2001 Feb;69(2):627-39. doi: 10.1128/IAI.69.2.627-639.2001.
6
Population structure of rat-derived Pneumocystis carinii in Danish wild rats.丹麦野生大鼠中源自大鼠的卡氏肺孢子虫的种群结构
Appl Environ Microbiol. 2000 Nov;66(11):4954-61. doi: 10.1128/AEM.66.11.4954-4961.2000.
7
Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods.商业大鼠群体中的潜伏性卡氏肺孢子虫感染:诱导性免疫抑制剂联合组织病理学、聚合酶链反应和血清学作为检测方法的比较
J Clin Microbiol. 1999 May;37(5):1441-6. doi: 10.1128/JCM.37.5.1441-1446.1999.

本文引用的文献

1
Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction.通过聚合酶链反应检测痰液和支气管肺泡灌洗样本中的卡氏肺孢子虫DNA。
J Clin Microbiol. 1993 Feb;31(2):221-6. doi: 10.1128/jcm.31.2.221-226.1993.
2
Genetic stability and diversity of Pneumocystis carinii infecting rat colonies.感染大鼠群体的卡氏肺孢子虫的遗传稳定性和多样性。
Infect Immun. 1993 Nov;61(11):4801-13. doi: 10.1128/iai.61.11.4801-4813.1993.
3
DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states.实验性肺孢子菌病中的DNA扩增:血清卡氏肺孢子菌DNA的特征及潜在的卡氏肺孢子菌携带状态
J Infect Dis. 1993 Aug;168(2):421-6. doi: 10.1093/infdis/168.2.421.
4
Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.用于定量检测血浆中1型人类免疫缺陷病毒RNA的快速简易聚合酶链反应检测法:在急性逆转录病毒感染中的应用
J Clin Microbiol. 1994 Feb;32(2):292-300. doi: 10.1128/jcm.32.2.292-300.1994.
5
Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia.长期使用和停用皮质类固醇期间淋巴细胞的变化:与卡氏肺孢子虫肺炎的关系。
J Immunol. 1984 Nov;133(5):2502-8.
6
Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines.卡氏肺孢子虫:A549和WI-38 VA13人类细胞系中的生长变量及评估
Exp Parasitol. 1985 Aug;60(1):43-54. doi: 10.1016/s0014-4894(85)80021-7.
7
Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.实验性卡氏肺孢子虫肺炎治疗评估中组织学和定量技术的比较
Antimicrob Agents Chemother. 1987 Feb;31(2):197-201. doi: 10.1128/AAC.31.2.197.
8
Genomic sequence of a Sprague-Dawley rat beta-globin gene.一只斯普拉格-道利大鼠β-珠蛋白基因的基因组序列。
Nucleic Acids Res. 1988 Mar 25;16(5):2342. doi: 10.1093/nar/16.5.2342.
9
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.阳离子抗锥虫药及其他抗菌药物在实验性卡氏肺孢子虫肺炎治疗中的应用
Antimicrob Agents Chemother. 1988 Jun;32(6):896-905. doi: 10.1128/AAC.32.6.896.
10
Molecular probes for the detection of Pneumocystis carinii.
Trans R Soc Trop Med Hyg. 1990;84 Suppl 1:17-8. doi: 10.1016/0035-9203(90)90450-s.